Answers are grounded in this paper and cite their sources.
To analyze changes in angiogenesis factors after transarterial radioembolization (TARE) with Yttrium-90-loaded resin microspheres in hepatocellular carcinoma (HCC) patients. METHODSInterleukin-6, interleukin-8, hepatocyte growth factor, platelet-derived growth factor, fibroblast growth factor, vascular endothelial growth factor-A (VEGF-A), and angiopoietin-2 levels in 26 patients were measured before TARE and on day 1, 7, 14, and 30 after TARE and evaluated regarding radiological response. RESULTSIn the sixth month of follow-up, 11 (42.30%)patients had a complete or partial response to treatment, while progressive disease was found in 15 (57.69%) patients.The percentage changes in VEGF-A in the non-responders on day 30 (P = 0.034) after TARE were significantly more obvious.Peak formation rates of VEGF-A were higher in non-responders (P = 0.036). CONCLUSIONShort-term changes in angiogenesis factors in HCC patients after TARE with Yttrium-90-loaded resin microspheres fluctuate with different amplitudes at different times.The upregulation of growth factors has a prognostic capacity.Changes in VEGF-A after TARE may be helpful for the early recognition of non-responders.
No takes yet. Share an insight, caveat, or question.
Ballı et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: